Placebo
37
5
6
26
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.4%
2 terminated out of 37 trials
92.9%
+6.3% vs benchmark
3%
1 trials in Phase 3/4
12%
3 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 26 completed trials
Clinical Trials (37)
Acute Caffeine Intake in Young vs Older Adults
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
Naltrexone for Prolonged Grief Disorder
Neural Correlates of Hypoalgesia Driven by Observation
Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain
Effects of 8 Weeks of Turmeric Ingestion on Physiology and Wellbeing in Healthy Older Adults
Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
Caffeinated Chewing Gum on Special Forces Performance
Effects of Low-intensity Transcranial Magnetic Stimulation on Major Depressive Disorder, and on 5-hydroxyindoleacetic Acid and Brain-derived Neurotrophic Factor Levels
Nitrate Formulations and Exercise Performance
TetraSOD® Supplementation and Skeletal Muscle Redox Gene Expression
Acute Effects of Beetroot Juice and Caffeine Co-ingestion on Lower-limb Strength and Muscular Endurance in Females
Beetroot Juice Effects on Contractile or Neuromuscular Properties in Male Trained Sprinters
Caffeinate Chewing Gum on Ice Hockey Performance
Caffeinated Chewing Gum on 400-meter Performance
Caffeine & Bodybuilding Dehydration Ability
Effects of Expectations on Negative Affect, Perceived Cognitive Effort, and Pain
Effects on CK, RPE, VAS Scale and Physical Performance of Three Recovery Methods in Elite Basketball Players
Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes